The present invention falls within the fields of pharmacy, medicine, chemistry and biotechnology. The compound of the present invention is a peptide and has shown surprising stability and ease of handling in comparison to the most similar peptide compounds. The pharmaceutical composition of the invention comprises said peptide compound and has shown surprising therapeutic results even when administered orally. In some embodiments, administration of the composition of the invention has delivered superior therapeutic results in comparison to the effects of hemopressin and cannabidiol. In some embodiments, oral administration of the composition of the invention provides significant and surprising results with respect to neuromodulation, in both curative and prophylactic treatment of convulsions, pain threshold modulation and important neuroprotection, also substantially reducing the clinical symptoms of multiple sclerosis.
